Nama Insights

Moderna Inc (MRNA)

Healthcare · Biotechnology · NASDAQ

S&P 500
Moderna Inc (MRNA) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $23.62B and a free-cash-flow yield of -9.0%. Over the most recent reported fiscal year, revenue declined 39.9%.
Market cap$23.62B
Trailing P/E
FCF yield-9.0%
Revenue growth (YoY)-39.9%
EPS growth (YoY)
FCF/share growth (YoY)
ExchangeNASDAQ
SectorHealthcare
IndustryBiotechnology
Explore live MRNA data on Nama Insights →

Recent Congressional trades

Moderna Inc trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member Chamber Trade Amount Disclosed
Rob Bresnahan House Sell $1,001 - $15,000 Apr 8, 2025
Julie Johnson House Sell $1,001 - $15,000 Feb 7, 2025
Josh Gottheimer House Sell $1,001 - $15,000 Mar 5, 2024
Marie Newman House Sell $1,001 - $15,000 Mar 1, 2021
Marie Newman House Sell $15,001 Mar 1, 2021
Marie Newman House Sell $1,001 - $15,000 Feb 3, 2021
Marie Newman House Buy $1,001 - $15,000 Feb 3, 2021
Marie Newman House Sell $15,001 - $50,000 Feb 3, 2021
Marie Newman House Sell $1,001 - $15,000 Feb 3, 2021